Integrated computational and experimental evaluation of grossamide as a natural product scaffold for dual carbohydrase inhibition in diabetes.

Despite the widespread use of Grossamide-containing plants in traditional medicine and its documented anti-inflammatory and metabolic regulatory properties, this lignanamide's potential as an antidiabetic agent remains unexplored. Current α-glucosida…

Preview only. Read the full abstract at the source